Terry Lo

Terry pioneered and led the early commercial success of spatial biology and mIF, first as GM for PerkinElmer’s tissue business, and then as President of Akoya Biosciences. Prior to this, Terry led the global adoption of HPV testing for cervical cancer primary screening at Roche Molecular. Terry also has extensive experience in International markets including GM of China and Japan, and Head of International Strategy at Hologic, and Director of Corporate BD APAC at BMS.

Top